MillhouseIAG Private Equity News
- Volume #1 March 2007
- Volume #2 May 2007
- Volume #3 July 2007
- Volume #4 September 2007
- Volume #5 November 2007
- Volume #6 January 2008
- Volume #7 March 2008
- Volume #8 May 2008
- Volume #9 July 2008
- Volume #10 September 2008
MillhouseIAG Private Equity Fund
- Product Disclosure Statement
- Aegis Equities Rating Report
- Fund at a glance
- Quarterly Fund Profile
- Performance Table
MillhouseIAG Private Equity Trusts #1 & #2
Global Sports Private Equity Fund
Private Equity Case Studies
- Millhouse IAG Performance History
- Traditional vs MillhouseIAG Private Equity fund structure
- Case Study: Deutsche Life Sciences
- Berlin Heart: Investment to Exit
- Case Study: Medical Enzymes AG
- Condat AG:Deutsche IT
- Benchmarking Case Study
Private Client Newsletter
Press Releases
- "Overseas Investment working well for Millhouse" Australian Venture Capital Journal July 2007
- "Boutique Fund Manager Attracts Strategic Investor" Australian Venture Capital Journal May 2007
- "Ascalon backs MillhouseIAG's Global Private Equity Push" - Australian Venture Capital Journal
- "Venture Capital : Build intellectual property depth first, then seek investment" - Biotechnology News
- "Mentors who mean business" - Courier Mail
Industry Articles
Other Files
MillhouseIAG Publications
- 2007 enterpriseangels 'Angels' Survey Results
- 2007 Corporation Builders Medium Sized Companies Survey Results
(Please note that past performance is not necessarily indicitive of future performances.)
General Advice Warning
The advice contained on this website is general advice. It has been prepared without taking account of any person's objectives, financial situation or needs and because of that, any person should, before acting on the advice, consider the appropriateness of the advice, having regard to the client's objectives, financial situation and needs. If the advice relates to the acquisition or possible acquisition, of a particular financial product - the client should obtain a Product Disclosure Statement relating to the product and consider the Statement before making any decision about whether to acquire the product.